In this episode, Bea talks to Dr. Thomas Fessard, founder and CEO of SpiroChem, a Swiss fine chemicals company that specialises in the design, synthesis, production, and commercialisation of novel building blocks for use in drug discovery.

Thomas tells the story of SpiroChem, from founding it 10 years ago to growing into its current state of having a worldwide customer base of the top pharma companies and one of the largest, most diverse collections of building blocks that can be used by pharma to assemble.

Thomas gives an introduction into spirocyclic molecules and the use of AI in computational chemistry to generate novel molecules in silico. He also talks about the automation of the chemical industry and how a company can protect its intellectual property from being lost.

To learn more about SpiroChem, visit their website at https://spirochem.com

For examples of the spirocyclic molecules, see:

https://ibb.co/f1gJq8v

You can follow us on:

Twitter: https://twitter.com/MPPhdnetPodcast

Instagram: https://www.instagram.com/offspringmagazine_thepodcast

Linkedin: https://www.linkedin.com/company/offspring-magazine-the-podcast

If you have any feedback, comments or suggestions, reach out to us at [email protected]

Check out the Offspring-Blog where we publish articles on a regular basis: https://www.phdnet.mpg.de/offspring-blog

Intro - Outro music composed by Srinath Ramkumar: https://twitter.com/srinathramkumar

Pre-Intro jingle composed by Gustavo Carrizo: https://www.instagram.com/carrizo.gus

See you in a week, Stay Safe and Stay Healthy!